Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Q3 2025 value amounting to 0.19%.

  • Harmony Biosciences Holdings' Return on Invested Capital changed 0.0% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.2% for FY2024, which is 900.0% down from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Return on Invested Capital of 0.19% as of Q3 2025, which was down 0.0% from 0.2% recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Return on Invested Capital high stood at 0.61% for Q3 2022, and its period low was 0.17% during Q1 2025.
  • For the 4-year period, Harmony Biosciences Holdings' Return on Invested Capital averaged around 0.33%, with its median value being 0.27% (2024).
  • The largest annual percentage gain for Harmony Biosciences Holdings' Return on Invested Capital in the last 5 years was 800bps (2023), contrasted with its biggest fall of -2900bps (2023).
  • Harmony Biosciences Holdings' Return on Invested Capital (Quarter) stood at 0.56% in 2022, then crashed by -53bps to 0.26% in 2023, then tumbled by -31bps to 0.18% in 2024, then grew by 3bps to 0.19% in 2025.
  • Its Return on Invested Capital stands at 0.19% for Q3 2025, versus 0.2% for Q2 2025 and 0.17% for Q1 2025.